10481-0112 NDC - MONSELS SOLUTION ()

Drug Information

Product NDC: 10481-0112

Proprietary Name: MONSELS SOLUTION

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Gordon Laboratories
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:2/9/2010

Package Information

No. Package Code Package Description Billing Unit
110481-0112-259 g in 1 BOTTLE, GLASS (10481-0112-2)ML
210481-0112-88 g in 1 BOTTLE, GLASS (10481-0112-8)ML

NDC Record

Field Name Field Value Definition
PRODUCT NDC10481-0112The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMONSELS SOLUTIONThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE12/7/2011This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEGordon LaboratoriesName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC10481-0112The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMONSELS SOLUTIONThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE2/9/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEGordon LaboratoriesName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023